Imagine seeing a digital reflection of your patient. Not just their chart, but a living, learning simulation of their physiology.

That’s the promise of digital twin models in medicine, and it’s closer to reality than you might think.

Until recently, this idea felt more like science fiction than actual science. But with advances in multimodal AI, continuous data streams, and simulation modeling, we’re closer than ever to building virtual versions of our patients that can predict responses before they happen.

What’s a Digital Twin?

A digital twin is a computational model of a patient’s body. It’s built from their genetics, labs, imaging, wearables, and lifestyle data and evolves over time. It allows clinicians to simulate interventions and forecast likely outcomes.

That’s a game-changer for personalized medicine. Instead of asking, “What’s the average response to this peptide or protocol?”, we can start asking, “What’s the likely response for this specific patient?”

Full Speed Ahead: The Science Is Moving Fast

While still in its early phases, digital twin technology has already shown promise in oncology and cardiology. As large language models (LLMs) get more sophisticated, they build out the technology needed to create functional digital twins with predictive capabilities that can forecast health outcomes (i.e., deliver healthcasts) over different time horizons:

  • 24 hours: Anticipating ICU deterioration or sepsis risk before it happens.

  • 13 weeks: Modeling tumor response in non-small-cell lung cancer to refine treatment strategy.

  • 24 months: Forecasting cognitive decline in Alzheimer’s disease to enable earlier intervention.

These aren’t static dashboards. They’re dynamic simulations that learn from continuous streams of data: labs, imaging, wearables, and patient-reported metrics. The result is a living view of physiology that updates as the patient changes.

And this is only just the start. The growing market for digital twins (across a range of industries) is expected to be $73.5 billion by 2027. This technology will be all around us soon.

Early innovators like Jona are already demonstrating what’s possible, integrating gut microbiome data to model system-wide physiology in real time. These advances mark a shift from retrospective review to living prediction, where every data point refines the care you deliver next.

Why This Matters for Clinicians

These tools are only as valuable as the humans who interpret them, and the clinicians that help patients build their “health portfolio" of data.

Predictive models can project risk trajectories, identify likely responders, or simulate the effect of combining lifestyle changes with pharmacologic interventions. But the real power lies in the way clinicians use these forecasts to align with patients, turning prediction into precision, and data into direction.

Here’s where you come in: Your role shifts from reactive problem-solver to strategic health planner. Think of yourself more like a wealth manager for wellbeing, guiding patients toward compounding health returns.

📙 Your Homework: While fully dynamic twins are still emerging, you can start integrating predictive thinking into your clinical workflow:

  1. Use AI to help you see what’s coming, not just record what’s happening. Tools like Freed or Vibrant can flag follow up priorities across visits, Oura predicts early signs of illness or cycle shifts, and TruNeura tracks cognitive improvements in real time to reveal how interventions are working.

  2. Co-create a “Health Roadmap.” Take a page from financial advisors’ playbook and plan for long-term wins. Align with patients on their predicted health trajectory and key intervention milestones.

  3. Track deltas, not just data. Focus on rate-of-change in biomarkers and behavior rather than one-time snapshots.

The most exciting frontier is already forming.

Today’s digital twins draw largely from hospital and registry data, but the next generation will merge insights from body composition scans, cognitive and lifestyle monitoring, and multi-omic platforms, creating continuous, personalized feedback loops between visits.

That’s where the promise becomes personal: a feedback system that continuously learns from each patient and informs your next decision, helping you intervene earlier, personalize more precisely, and keep patients progressing between appointments.

The takeaway: The future of clinical care isn’t reactive, it’s proactive. Digital twins turn intuition into prediction, and foresight into action.

How I AI with Leo Grady, founder of Jona

This week on How I AI, we sat down with Leo Grady, Ph.D., the founder of Jona. The company uses AI to understand the individual’s gut microbiome, then provides insights tailored uniquely to the individual.

The process start with a lab test. Using the resulting data, Jona creates a digital twin of that patient’s gut. Then, Jona’s AI system matches that person’s individual data to the hundreds of thousands of published studies about what impacts the microbiome. By using study data and the digital twin to model how different changes — like going vegan or keto — would impact the individual, Jona saves people from the time and energy drain of trying different changes to find what works.

With Jona, Dr. Grady and his team aim to deliver on what so many clinicians dream about: parsing the thousands of studies coming out each month and pulling out what’s relevant to the individual patient.

With this kind of support, Dr. Grady says clinicians can better serve three core camps of patients:

  • The Source Seekers: Many patients seek medical care when they’re experiencing a health issue and want to get to the bottom of it. This kind of extremely granular testing paired with deep health data analysis/matching helps them do precisely that.

  • The Builders of Better: Other patients see a doctor (particularly a longevity care provider) when they want to feel better, look better, or perform better. Jona gives clinicians a way to support the individual goals of folks like athletes and biohackers.

  • The Peace-of-Mind Party: Finally, Dr. Grady points out that many people simply want to know that they’re generally healthy and doing what they should to avoid future issues. By looking at the gut microbiome — which connects to so many other health factors — clinicians can help them feel good about their choices or adjust them as needed.

All of this gets particularly powerful when this kind of care is applied over time. With the digital twin and retesting, providers can see how adjustments affect the individual. This allows them to better tailor their care.

Leo’s philosophy in building Jona:

📙 Your Homework: Pick one patient from each of the three camps above. Explore how you can use AI-backed tech to help them with their goal, whether that’s getting to the root of a specific condition, supporting their general wellness, or upping their game.

👉🏽 Learn more live: Join Leo Grady of Jona and Sunita Mohanty of Vibrant Practice in an upcoming webinar on 10/28 at 9am PT / noon ET on “AI Made Simple: What Clinicians Need to Know and How to Use it Today”.

Curious to test out Vibrant Practice? Our AI-powered platform is ready-made to create personalized care plans. Test out our sandbox today.

This Week in Clinical AI

  • How AI can improve heart attack risk assessment. The Lancet Digital Health published findings on a major international study led by the University of Zurich. 

    • GRACE 3.0: An AI model, called GRACE 3.0, was developed to re-analyze data from over 600,000 heart attack patients across 10 countries.

    • Personalized treatment: The study found that while some patients greatly benefited from early invasive treatments like stenting, others received little to no benefit, indicating a need to re-evaluate treatment strategies globally.

    • Improved accuracy: By analyzing large-scale datasets, the AI was able to classify patient risk for non-ST-elevation acute coronary syndrome (NSTE-ACS) more accurately than existing methods. 

  • The New England Journal of Medicine publishes its first AI-generated diagnosis. Researchers at Harvard Medical School created an AI system they call Dr. CaBot. Because Dr. CaBot has functionality that allows it to explain its reasoning, its diagnosis was eligible to be included in a medical case discussion published in the NEJM earlier this month.

  • AI tool beats humans at distinguishing between look-alike brain cancers. Primary central nervous system lymphoma (PCNSL) and glioblastoma look similar under a microscope, often leading to misdiagnosis. But tests showed that the AI-backed Pathology Image Characterization Tool with Uncertainty-aware Rapid Evaluations (PICTURE) can tell the two apart 98% of the time. That far trumps human pathologists, with their misdiagnosis rate of 38%.

  • Upcoming event: Columbia launches new seminar series on AI and aging. The Columbia Aging Center just launched a new virtual seminar called “AI + Healthy Longevity.” Registration is now open for the next virtual session on deploying AI Innovations to change aging, which will be held October 30.

👋 Welcome New Readers

The Modern Clinician is written for functional, integrative, and longevity-focused physicians who want to scale their impact and deliver cutting-edge care.

If you liked this one, share it with a colleague! We appreciate you spreading the word.

To learn more about the why behind this newsletter, start with our first post introducing The Modern Clinician.

Keep Reading

No posts found